CN1709417A - 一种杏香兔耳风提取物及其制备方法 - Google Patents
一种杏香兔耳风提取物及其制备方法 Download PDFInfo
- Publication number
- CN1709417A CN1709417A CN 200510075384 CN200510075384A CN1709417A CN 1709417 A CN1709417 A CN 1709417A CN 200510075384 CN200510075384 CN 200510075384 CN 200510075384 A CN200510075384 A CN 200510075384A CN 1709417 A CN1709417 A CN 1709417A
- Authority
- CN
- China
- Prior art keywords
- fragrans champ
- extract
- ainsliasa fragrans
- gained
- ainsliasa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000284 extract Substances 0.000 title claims abstract description 44
- 238000000034 method Methods 0.000 title claims abstract description 23
- 241001038618 Ainsliaea fragrans Species 0.000 title abstract description 12
- 238000000605 extraction Methods 0.000 claims abstract description 15
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- 102000004190 Enzymes Human genes 0.000 claims abstract description 10
- 108090000790 Enzymes Proteins 0.000 claims abstract description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 239000003814 drug Substances 0.000 claims description 20
- 239000011347 resin Substances 0.000 claims description 16
- 229920005989 resin Polymers 0.000 claims description 16
- 229940079593 drug Drugs 0.000 claims description 10
- 238000009835 boiling Methods 0.000 claims description 9
- 239000012567 medical material Substances 0.000 claims description 9
- 229930003944 flavone Natural products 0.000 claims description 8
- 235000011949 flavones Nutrition 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 7
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000003480 eluent Substances 0.000 claims description 4
- 150000002212 flavone derivatives Chemical class 0.000 claims description 4
- 150000002213 flavones Chemical class 0.000 claims description 4
- 238000001291 vacuum drying Methods 0.000 claims description 4
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 238000010828 elution Methods 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 230000008020 evaporation Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- -1 lactone compound Chemical class 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 2
- 230000000415 inactivating effect Effects 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 7
- 239000000470 constituent Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000001035 drying Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 3
- 239000003463 adsorbent Substances 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 238000002242 deionisation method Methods 0.000 description 3
- 238000004064 recycling Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000003795 desorption Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 240000004460 Tanacetum coccineum Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 201000003988 chronic cervicitis Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007560 sedimentation technique Methods 0.000 description 1
- 229930009674 sesquiterpene lactone Natural products 0.000 description 1
- 150000002107 sesquiterpene lactone derivatives Chemical class 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 剂量(mg·kg-1) | 例数(n) | 药前足体积(ml) | 肿胀率(%)/肿胀抑制率(%) | ||||
1h | 2h | 3h | 4h | 5h | ||||
溶媒对照 | - | 10 | 1.01±0.06 | 30.14±9.53- | 53.85±8.77- | 63.81±6.01- | 58.79±8.07- | 56.26±8.59- |
阿斯匹林 | 100 | 10 | 1.07±0.05 | 18.57±6.478**38.39 | 17.95±4.65**66.67 | 28.30±9.2855.65 | 35.22±11.13**40.09 | 35.21±7.97**37.42 |
T2 | 1840 | 10 | 1.02±0.09 | 27.95±7.447.27 | 39.80±13.03*26.09 | 50.34±12.52**21.22 | 60.81±12.81- | 54.04±12.593.96 |
T3 | 210 | 10 | 0.99±0.06 | 22.03±6.42*26.91 | 37.46±10.62**30.44 | 49.67±11.96**22.16 | 51.30±9.5212.74 | 47.26±10.6116.00 |
溶媒对照 | - | 10 | 1.02±0.06 | 22.85±3.33- | 23.42±4.39- | 26.10±6.30- | ||
T1 | 350 | 10 | 1.02±0.11 | 20.62±7.909.76 | 19.47±9.4416.90 | 15.20±10.06**41.76 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100753844A CN100475228C (zh) | 2005-06-16 | 2005-06-16 | 一种杏香兔耳风提取物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100753844A CN100475228C (zh) | 2005-06-16 | 2005-06-16 | 一种杏香兔耳风提取物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1709417A true CN1709417A (zh) | 2005-12-21 |
CN100475228C CN100475228C (zh) | 2009-04-08 |
Family
ID=35705748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100753844A Expired - Fee Related CN100475228C (zh) | 2005-06-16 | 2005-06-16 | 一种杏香兔耳风提取物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100475228C (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101318946B (zh) * | 2008-04-10 | 2010-11-10 | 中国人民解放军第二军医大学 | 化合物二聚兔耳风萜a及其制备方法和应用 |
CN101664427B (zh) * | 2009-09-15 | 2011-08-10 | 江西天施康中药股份有限公司 | 一种含杏香兔耳风提取物中药制剂的制备方法 |
CN101293003B (zh) * | 2008-06-17 | 2011-10-26 | 江西佑美制药有限公司 | 一种杏香兔耳风有效部位及其制备方法和应用 |
CN101332216B (zh) * | 2008-05-20 | 2012-06-06 | 北京星昊医药股份有限公司 | 杏香兔耳风总酚酸提取物及其制备方法 |
CN108014157A (zh) * | 2017-12-31 | 2018-05-11 | 长沙湘资生物科技有限公司 | 杏香兔耳风提取物在抗菌消炎药物中的应用 |
CN115040476A (zh) * | 2022-06-24 | 2022-09-13 | 武昌理工学院 | 一种复方血三七降糖口服液及其制备方法和应用 |
-
2005
- 2005-06-16 CN CNB2005100753844A patent/CN100475228C/zh not_active Expired - Fee Related
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101318946B (zh) * | 2008-04-10 | 2010-11-10 | 中国人民解放军第二军医大学 | 化合物二聚兔耳风萜a及其制备方法和应用 |
CN101332216B (zh) * | 2008-05-20 | 2012-06-06 | 北京星昊医药股份有限公司 | 杏香兔耳风总酚酸提取物及其制备方法 |
CN101293003B (zh) * | 2008-06-17 | 2011-10-26 | 江西佑美制药有限公司 | 一种杏香兔耳风有效部位及其制备方法和应用 |
CN101664427B (zh) * | 2009-09-15 | 2011-08-10 | 江西天施康中药股份有限公司 | 一种含杏香兔耳风提取物中药制剂的制备方法 |
CN108014157A (zh) * | 2017-12-31 | 2018-05-11 | 长沙湘资生物科技有限公司 | 杏香兔耳风提取物在抗菌消炎药物中的应用 |
CN115040476A (zh) * | 2022-06-24 | 2022-09-13 | 武昌理工学院 | 一种复方血三七降糖口服液及其制备方法和应用 |
CN115040476B (zh) * | 2022-06-24 | 2023-04-21 | 武昌理工学院 | 一种复方血三七降糖口服液及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN100475228C (zh) | 2009-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1919222A (zh) | 一种三七总皂苷的制备方法 | |
CN100475228C (zh) | 一种杏香兔耳风提取物及其制备方法 | |
CN101062074A (zh) | 冬虫夏草菌和三七提取物的组合物及其在防治肺纤维化上的应用 | |
CN101057890A (zh) | 一种治疗冠心病的中药组合物及其制备方法、制剂和其应用 | |
CN1923194A (zh) | 一种秦皮提取物的制备方法和用途 | |
CN100502880C (zh) | 一种三七二醇皂苷组合物及其制备方法和用途 | |
CN1989984A (zh) | 川芎有效组分、制备方法及其制剂与用途 | |
CN1682971A (zh) | 一种复方板蓝根冻干粉针剂及其制备方法 | |
CN100371340C (zh) | 胡黄连苷ii单体的制备方法及其治疗乙型肝炎的药物剂型 | |
CN101618069B (zh) | 一种兼治瘀肿、出血和镇痛的胶囊制剂,其制备方法及用途 | |
CN100584345C (zh) | 具抗病毒作用的小紫金牛提取物及其提取方法和应用 | |
CN1068782C (zh) | 以栾树提取物为有效组分的抗癌药物及制备方法 | |
CN1282468C (zh) | 中药脑得生软胶囊及其制备方法 | |
CN1284535C (zh) | 一种联苯环辛二烯木脂素在制备抗肿瘤药物的用途 | |
CN1264506C (zh) | 一种丹参素的药物组合物的制备方法 | |
CN110585193B (zh) | 一种二芳基丁内酯类木脂素类化合物在制备抗肝纤维化药物中的应用 | |
CN1943609A (zh) | 一种具有抗病毒作用的药物组合物及其制备方法 | |
CN111388542A (zh) | 一种从白芍非药用部位提取单萜苷类有效成分的方法 | |
CN1887338A (zh) | 参莲颗粒的制备方法及质量控制技术 | |
CN1709416A (zh) | 陆英提取物及其制备方法 | |
CN1887316A (zh) | 一种中药组合物及其制备方法和应用 | |
CN1679795A (zh) | 水杨梅根抗肿瘤提取物及其制备方法和用途 | |
CN1739548A (zh) | 治疗肝癌的虎眼万年青多糖药物 | |
CN100383155C (zh) | 抱茎苦荬菜内酯及其衍生物组合物和它的制备方法及其应用 | |
CN1150918C (zh) | 珠子参有效成份制剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI ZHONGCHUANG PHARMACEUTICAL TECHNOLOGY CO Free format text: FORMER OWNER: JIANGXI HUIREN PHARMACEUTICAL CO., LTD. Effective date: 20070330 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20070330 Address after: 201203 Zhangjiang hi tech park, Li Shizhen Road, No. 396, third, fourth floor, Shanghai Applicant after: SHANGHAI ZHONGCHUANG PHARMACEUTICAL TECHNOLOGY CO.,LTD. Address before: 330043 1189 Yingbin Avenue, Nanchang, Jiangxi Applicant before: Jiangxi Huiren Pharmaceutical Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160105 Address after: 201203, Li Shizhen road 396, Zhangjiang hi tech park, Shanghai Patentee after: Shanghai Kin Kun Pharmaceutical Co.,Ltd. Address before: 201203 Zhangjiang hi tech park, Li Shizhen Road, No. 396, third, fourth floor, Shanghai Patentee before: SHANGHAI ZHONGCHUANG PHARMACEUTICAL TECHNOLOGY CO.,LTD. |
|
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 201203 No. 396 Li Shizhen Road, Shanghai, China (Shanghai) free trade test area Patentee after: Shanghai Kin Kun Pharmaceutical Co.,Ltd. Address before: 201203, Li Shizhen road 396, Zhangjiang hi tech park, Shanghai Patentee before: Shanghai Kin Kun Pharmaceutical Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090408 |
|
CF01 | Termination of patent right due to non-payment of annual fee |